Canagliflozin impairs T cell effector function via metabolic suppression in autoimmunity

Benjamin J Jenkins, Julianna Blagih, Fernando M Ponce-Garcia, Mary Canavan, Nancy Gudgeon, Simon Eastham, David Hill, Megan M Hanlon, Eric H Ma, Emma L Bishop, April Rees, James G Cronin, Elizabeth C Jury, Sarah K Dimeloe, Douglas J Veale, Catherine A Thornton, Karen H Vousden, David K Finlay, Ursula Fearon, Gareth W JonesLinda V Sinclair, Emma E Vincent, Nicholas Jones^*

^*Corresponding author for this work

School of Cellular and Molecular Medicine
Bristol Doctoral College
Bristol Medical School (THS)
Bristol Population Health Science Institute
Cancer
Infection and Immunity

Research output: Contribution to journal › Article (Academic Journal) › peer-review

39 Citations (Scopus)

1 results

Filter

Active
8074 (C18281/A29019) ICEP2 - Programme Award: Towards improved casual evidence and enhanced prediction of cancer risk and survival
Martin, R. M. (Principal Investigator)
1/10/20 → 30/09/25
Project: Research

Canagliflozin impairs T cell effector function via metabolic suppression in autoimmunity

Projects

Search results

8074 (C18281/A29019) ICEP2 - Programme Award: Towards improved casual evidence and enhanced prediction of cancer risk and survival